Development and validation of an administrative case definition for inflammatory bowel diseases

Canadian Journal of Gastroenterology

Volumn 26, Issue 10, 2012, Pages 711-717

  Rezaie, Ali ^a   Quan, Hude ^b   Fedorak, Richard N ^c   Panaccione, Remo ^a   Hilsden, Robert J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Administrative database; Crohn disease; Epidemiology; Inflammatory bowel diseases; Population based data; Ulcerative colitis

Indexed keywords

AMBULATORY CARE; ARTICLE; CANADA; CASE CONTROL STUDY; CHRONIC DISEASE; CONTROLLED STUDY; CROHN DISEASE; DATA BASE; ENTERITIS; GASTROINTESTINAL ENDOSCOPY; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS; VALIDATION STUDY;

EID: 84867482967     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2012/278495     Document Type: Article

References (23)

1. Romano C, Famiani A, Gallizzi R, Comito D, Ferrau' V, Rossi P. Indeterminate colitis: A distinctive clinical pattern of inflammatory bowel disease in children. Pediatrics 2008;122:e1278-81.
2. Rubin GP, Hungin AP, Kelly PJ, Ling J. Inflammatory bowel disease: Epidemiology and management in an English general practice population. Aliment Pharmacol Ther 2000;14:1553-9. (Pubitemid 32011728)
3. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-17.
4. Pinchbeck BR, Imes S, Dinwoodie A, Thomson AB. Discriminant function analysis to calculate a Crohn's activity group scale to predict future inactive or active disease. J Clin Gastroenterol 1988;10:498-504.
5. Loftus CG, Loftus EV Jr, Harmsen WS, et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007;13:254-61. (Pubitemid 46465905)
6. Kurata JH, Kantor-Fish S, Frankl H, Godby P, Vadheim CM. Crohn's disease among ethnic groups in a large health maintenance organization. Gastroenterology 1992;102:1940-8.
7. Stowe SP, Redmond SR, Stormont JM, et al. An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology 1990;98:104-10. (Pubitemid 20017790)
8. Hiatt RA, Kaufman L. Epidemiology of inflammatory bowel disease in a defined northern California population. West J Med 1988;149:541-6.
9. Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada: A population-based study. Am J Gastroenterol 2006;101:1559-68. (Pubitemid 43980630)
10. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: A population-based study. Am J Epidemiol 1999;149:916-24. (Pubitemid 29230706)
11. Rezaie A. Development of an ICD coding definition for inflammatory bowel disease (Master's thesis). 〈www.dspace.ucalgary.ca/bitstream/1880/.../3/ Rezaie-MSc-2007-Med.pdf〉. Alberta: University of Calgary, 2007.
12. Pimentel M, Chang M, Chow EJ, et al. Identification of a prodromal period in Crohn's disease but not ulcerative colitis. Am J Gastroenterol 2000;95:3458-62.
13. Farrokhyar F, McHugh K, Irvine EJ. Self-reported awareness and use of the International Classification of Diseases coding of inflammatory bowel disease services by Ontario physicians. Can J Gastroenterol 2002;16:519-26.
14. Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: Determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002;25:512-6. (Pubitemid 41103345)
15. Benchimol EI, Guttmann A, Griffiths AM, et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: Evidence from health administrative data. Gut 2009;58:1490-7.
16. Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32-5.
17. Studney DR, Hakstian AR. A comparison of medical record with billing diagnostic information associated with ambulatory medical care. Am J Public Health 1981;71:145-9. (Pubitemid 11167210)
18. Patten SB, Svenson LW, White CM, Khaled SM, Metz LM. Affective disorders in motor neuron disease: A population-based study. Neuroepidemiology 2007;28:1-7. (Pubitemid 46221022)
19. Hauck LJ, White C, Feasby TE, Zochodne DW, Svenson LW, Hill MD. Incidence of Guillain-Barre syndrome in Alberta, Canada: An administrative data study. J Neurol Neurosurg Psychiatry 2008;79:318-20. (Pubitemid 351303392)
20. Gao S, Manns BJ, Culleton BF, et al. Access to health care among status Aboriginal people with chronic kidney disease. CMAJ 2008;179:1007-12.
21. Sadowski DC, Ackah F, Jiang B, Svenson LW. Achalasia: Incidence, prevalence and survival. A population-based study. Neurogastroenterol Motil 2010;22:e256-61.
22. Chini F, Pezzotti P, Orzella L, Borgia P, Guasticchi G. Can we use the pharmacy data to estimate the prevalence of chronic conditions? A comparison of multiple data sources. BMC Public Health 2011;11:688.
23. Li B, Quan H, Fong A, Lu M. Assessing record linkage between health care and Vital Statistics databases using deterministic methods. BMC Health Serv Res 2006;6:48.